Deutsche Bank’s Starling Oncology, Inc. Warrant STLNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.86K | Hold |
96,600
| – | – | ﹤0.01% | 3639 |
|
|
2026
Q1 | $3.86K | Hold |
96,600
| – | – | ﹤0.01% | 3568 |
|
|
2025
Q4 | $11.6K | Sell |
96,600
-16,000
| -14% | -$2.58K | ﹤0.01% | 3544 |
|
|
2025
Q3 | $13.5K | Hold |
112,600
| – | – | ﹤0.01% | 3516 |
|
|
2025
Q2 | $5.63K | Hold |
112,600
| – | – | ﹤0.01% | 3517 |
|
|
2025
Q1 | $3.38K | Hold |
112,600
| – | – | ﹤0.01% | 3532 |
|
|
2024
Q4 | $1.13K | Hold |
112,600
| – | – | ﹤0.01% | 3573 |
|
|
2024
Q3 | $2.25K | Hold |
112,600
| – | – | ﹤0.01% | 3566 |
|
|
2024
Q2 | $3.38K | Hold |
112,600
| – | – | ﹤0.01% | 3512 |
|
|
2024
Q1 | $22.5K | Hold |
112,600
| – | – | ﹤0.01% | 3493 |
|
|
2023
Q4 | $14.6K | Sell |
112,600
-37,000
| -25% | -$5.85K | ﹤0.01% | 3516 |
|
|
2023
Q3 | $13.5K | Hold |
149,600
| – | – | ﹤0.01% | 3536 |
|
|
2023
Q2 | $4.19K | Hold |
149,600
| – | – | ﹤0.01% | 3706 |
|
|
2023
Q1 | $9.13K | Hold |
149,600
| – | – | ﹤0.01% | 3795 |
|
|
2022
Q4 | $16.5K | Hold |
149,600
| – | – | ﹤0.01% | 3800 |
|
|
2022
Q3 | $83K | Hold |
149,600
| – | – | ﹤0.01% | 3418 |
|
|
2022
Q2 | $75K | Sell |
149,600
-25,400
| -15% | -$23.4K | ﹤0.01% | 3638 |
|
|
2022
Q1 | $201K | Hold |
175,000
| – | – | ﹤0.01% | 3262 |
|
|
2021
Q4 | $121K | Sell |
175,000
-25,000
| -13% | -$30.9K | ﹤0.01% | 3621 |
|
|
2021
Q3 | $246K | Sell |
200,000
-59,757
| -23% | -$82.3K | ﹤0.01% | 3460 |
|
|
2021
Q2 | $449K | Buy |
259,757
+35,501
| +16% | +$47.8K | ﹤0.01% | 3290 |
|
|
2021
Q1 | $303K | Buy |
224,256
+10,816
| +5% | +$20.1K | ﹤0.01% | 3404 |
|
|
2020
Q4 | $416K | Buy |
213,440
+14,184
| +7% | +$24.5K | ﹤0.01% | 3031 |
|
|
2020
Q3 | $339K | Hold |
199,256
| – | – | ﹤0.01% | 2882 |
|
|
2020
Q2 | $292K | Buy |
+199,256
| New | +$286K | ﹤0.01% | 2925 |
|